Ditchcarbon
  • Customers
  1. Organizations
  2. Adallen Pharma Limited
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated a month ago

Adallen Pharma Limited

Company website

Adallen Pharma Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2015, the company has rapidly established itself in key operational regions across Europe and beyond, focusing on advanced drug formulations and delivery systems. With a commitment to quality and efficacy, Adallen Pharma offers a range of core products, including prescription medications and over-the-counter solutions that address various health conditions. Their unique approach to research and development has led to several notable achievements, positioning them as a trusted name in the market. As they continue to expand their portfolio, Adallen Pharma remains dedicated to improving patient outcomes through cutting-edge pharmaceutical advancements.

DitchCarbon Score

How does Adallen Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Adallen Pharma Limited's score of 26 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.

50%

Let us know if this data was useful to you

Adallen Pharma Limited's reported carbon emissions

In 2023, Adallen Pharma Limited reported total carbon emissions of approximately 263,000 kg CO2e. This figure includes 600 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and 5,000 kg CO2e from Scope 2 emissions, mainly from purchased electricity (2,690 kg CO2e). The majority of their emissions, about 54,000 kg CO2e, fall under Scope 3, which encompasses various activities such as employee commuting (1,400 kg CO2e) and purchased goods and services (231,000 kg CO2e). Despite the significant emissions reported, Adallen Pharma Limited has not established specific reduction targets or initiatives as part of their climate commitments. There are no cascading emissions data from a parent company, indicating that all reported figures are directly from Adallen Pharma Limited. The company is currently not part of any recognised climate initiatives such as SBTi or CDP, nor have they made any formal climate pledges. Overall, while Adallen Pharma Limited has outlined their emissions profile, further commitments and reduction strategies will be essential for enhancing their sustainability efforts in the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
-
Scope 2
5,000
Scope 3
54,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Adallen Pharma Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Adallen Pharma Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Adallen Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Caligor Coghlan Pharma Services

US
•
Other business services (74)
Updated 12 days ago

Clinigen

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Bionical Limited

GB
•
Health and social work services (85)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250829.2
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy